Increase In Tax Threatens Pharmaceutical Sector

BMI View: Governments that implement policies to foster scientific innovation while offering lower operating costs will have a competitive advantage in attracting multinational drugmakers to their countries, creating highly-skilled jobs and supporting economic growth. Puerto Rico's new law, increasing taxation on multinational firms operating in the US-affiliated territory, may have adverse consequences that could affect pharmaceutical innovation and the island's overall

To read the full article, please choose one of the following options: